Send me a link:

*Text messaging rates may apply.

 Dow Down1.88% Nasdaq Down2.09%

Neurocrine Biosciences Inc. (NBIX)

-NasdaqGS
13.58 0.42(3.00%) Jul 31, 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue -   730   729   730  
Cost of Revenue -   -   -   -  
Gross Profit -   730   729   730  
Operating Expenses
Research Development8,572  8,918  9,490  10,527  
Selling General and Administrative4,153  3,342  3,245  3,370  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (12,725) (11,530) (12,006) (13,167)
Income from Continuing Operations
Total Other Income/Expenses Net883  888  875  925  
Earnings Before Interest And Taxes(11,842)(10,642)(11,131)(12,242)
Interest Expense -   -   -   -  
Income Before Tax(11,842)(10,642)(11,131)(12,242)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(11,842)(10,642)(11,131)(12,242)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (11,842) (10,642) (11,131) (12,242)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (11,842) (10,642) (11,131) (12,242)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.